Grace Therapeutics, Inc. (NASDAQ: GRCE) — Healthcare · Share Price, Chart & Market Data
About: Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.30 (-2.13%)
GRCEGrace Therapeutics, Inc.
Loading watchlist status…
Trade GRCE now
Grace Therapeutics, Inc. share price
GRCE price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:27 am GMT+0
GRCE price performance
-49.891%
5D
-48.198%
1M
-37.158%
YTD
-3.361%
1Y
GRCE price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:27 am GMT+0
GRCE details
GRCE Market Signals